Results 11 to 20 of about 1,133,949 (262)

RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity

open access: yesBMC Cancer, 2023
Background Endocrine-resistant breast cancers have elevated expression of XBP1, where it drives endocrine resistance by controlling the expression of its target genes.
David Barua   +5 more
doaj   +1 more source

Progression-free survival according to MTV.

open access: yes, 2022
Progression-free survival according to MTV.
Nina Jehanno (11949663)   +8 more
core   +1 more source

Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome In Vitro by Pharmacological Inhibition of Cdc42-Induced Actin Cytoskeleton Remodeling

open access: yesFrontiers in Immunology, 2021
Natural killer (NK) cells are innate effector lymphocytes with strong antitumor effects against hematologic malignancies such as chronic lymphocytic leukemia (CLL). However, NK cells fail to control CLL progression on the long term.
Hannah Wurzer   +16 more
doaj   +1 more source

Intraperitoneal Chemotherapy for Peritoneal Metastases: Technical Innovations, Preclinical and Clinical Advances and Future Perspectives

open access: yesBiology, 2021
(1) Background: Tumors of the peritoneal serosa are called peritoneal carcinosis. Their origin may be primary by primitive involvement of the peritoneum (peritoneal pseudomyxoma, peritoneal mesothelioma, etc.). This damage to the peritoneum can also be a
Niki Christou   +7 more
doaj   +1 more source

PDK1- and PDK2-mediated metabolic reprogramming contributes to the TGFβ1-promoted stem-like properties in head and neck cancer

open access: yesCancer & Metabolism, 2022
Background Resistance to chemotherapeutic drugs is a key factor for cancer recurrence and metastases in head and neck cancer (HNC). Cancer stem cells (CSCs) in tumors have self-renewal, differentiation, and higher drug resistance capabilities, resulting ...
Wan-Hsuan Sun   +4 more
doaj   +1 more source

Progress in Progression? [PDF]

open access: yesJournal of the American Society of Nephrology, 2010
Diabetic nephropathy is the major cause of ESRD in the United States.1 Unfortunately, only angiotensin-converting enzyme inhibitors or angiotensin type 1 receptor blockers are registered for slowing the progression of diabetic nephropathy—but they do not halt progression.2–5 Given that diabetic nephropathy costs the health care system close to $30 ...
openaire   +1 more source

Tumor Hybrid Cells: Nature and Biological Significance

open access: yesFrontiers in Cell and Developmental Biology, 2022
Metastasis is the leading cause of cancer death and can be realized through the phenomenon of tumor cell fusion. The fusion of tumor cells with other tumor or normal cells leads to the appearance of tumor hybrid cells (THCs) exhibiting novel properties ...
Maria S. Tretyakova   +4 more
doaj   +1 more source

Tumorigenicity of IL-1α– and IL-1β–Deficient Fibrosarcoma Cells

open access: yesNeoplasia: An International Journal for Oncology Research, 2008
Analyzing the growth of fibrosarcoma lines derived from IL-1α–, IL-1β–, or IL-1αβ–knockout (−/−) mice in the immunocompetent host revealed that tumor-derived IL-1α and IL-1β exert strong and opposing effects on immune response induction, which prohibited
Irina Nazarenko   +9 more
doaj   +1 more source

The miR-17-92 cluster: Yin and Yang in human cancers

open access: yesCancer Treatment and Research Communications, 2022
MicroRNAs (miRNAs) are non-coding RNAs which modulate gene expression via multiple post-transcriptional mechanisms. They are involved in a variety of biological processes, including cell proliferation, metastasis, metabolism, tumorigenesis, and apoptosis.
Wenyuan Zhao   +3 more
doaj   +1 more source

Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression

open access: yes, 2023
Background: Identifying a meaningful progression metric for Parkinson’s disease (PD) that reflects heterogeneity remains a challenge. Objective: To assess the frequency and baseline predictors of progression to clinically relevant motor and non-motor PD ...
Galasko, Douglas   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy